ARCHIVES

New FDA Commisioner’s Top Priorities: FDAMA Implimitation, Agency’s Science

This article is from The Cancer Letter archive.

Vol. 25 No. 01 | January 8, 1999

Download PDF Visit The Full Archive

Related Articles

House Disallows NCI Recision

March 14, 1975

DCPC Advisors Okay Minority Based CCOPs, RFA In Native Americans

January 15, 1993

Also von Eschenbach Role in Industry Program Raises New Concerns of Conflict of Interest.

November 22, 2006

In Brief: Wilson Names Director, MCW cancer Center; UAB Cancer Center Makes Three Appointments

February 9, 1996

DRCA Planning Described; New Cancer Control Conference Set

February 4, 1983

DCCR Merit Review Finds some Excellent contract Projects, Some Not So Good; Some Are Terminated

February 25, 1977